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Abstract
Background: Chest pain raises concern for the possibility of coronary heart disease. Scoring methods have been
developed to identify coronary heart disease in emergency settings, but not in primary care.
Methods: Data were collected from a multicenter Swiss clinical cohort study including 672 consecutive patients
with chest pain, who had visited one of 59 family practitioners’ offices. Using delayed diagnosis we derived a
prediction rule to rule out coronary heart disease by means of a logistic regression model. Known cardiovascular
risk factors, pain characteristics, and physical signs associated with coronary heart disease were explored to develop
a clinical score. Patients diagnosed with angina or acute myocardial infarction within the year following their initial
visit comprised the coronary heart disease group.
Results: The coronary heart disease score was derived from eight variables: age, gender, duration of chest pain
from 1 to 60 minutes, substernal chest pain location, pain increasing with exertion, absence of tenderness point at
palpation, cardiovascular risks factors, and personal history of cardiovascular disease. Area under the receiver
operating characteristics curve was of 0.95 with a 95% confidence interval of 0.92; 0.97. From this score, 413
patients were considered as low risk for values of percentile 5 of the coronary heart disease patients. Internal
validity was confirmed by bootstrapping. External validation using data from a German cohort (Marburg, n = 774)
revealed a receiver operating characteristics curve of 0.75 (95% confidence interval, 0.72; 0.81) with a sensitivity of
85.6% and a specificity of 47.2%.
Conclusions: This score, based only on history and physical examination, is a complementary tool for ruling out
coronary heart disease in primary care patients complaining of chest pain.
Background
Chest pain is a common complaint that occurs in 1 to
2% of primary care patients [1]. Chest pain raises con-
cerns about the occurrence of a serious condition such
as coronary heart disease (CHD) [2], which is present in
about 12% of primary care patients with chest pain
[1,3]. Family practitioners should be equipped to rule
out an acute CHD related event rapidly. They are used
to estimating the probability of CHD in a patient with
chest pain on the basis of pain characteristics, patient’s
age, gender, history and cardiovascular risk factors [4].
Cardiovascular risk factors and chest pain history are
associated with CHD, and have been widely studied
[4,5]. However, chest pain characteristics alone are not
sufficient to reliably rule out ischemic heart disease [6].
A more complete set of predictors is thus needed for
this purpose.
Predictive scores for CHD in emergency settings have
been developed [7-9], and are now implemented [10,11].
However, these scores are not necessarily useful in the
primary care setting [12]. To our knowledge, no ambu-
latory CHD score has been developed to support pri-
mary care physicians in ruling out CHD in patients with
chest pain. Such a score might help physicians, reassure
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spent on further investigations. The objective of this
study was to develop an ambulatory CHD predictive
score, based only on the patient’s history and physical
examination in the primary care setting, to rule out
CHD without further investigations of patients with
chest-pain.
Methods
Design overview
We used data from a multicenter clinical cohort of pri-
mary care patients with chest pain (TOPIC - Thoracic
Pain in Community) [3] to develop a clinical prediction
score for CHD, and secondarily the data from a study
conducted in Germany (Marburg study) to validate the
score [14]. The primary goal of both these studies was
to examine the frequency of occurrence, mode of pre-
sentation, etiology, clinical characteristics and correlates,
management strategies and outcomes in these patients.
Settings and participants
The initial survey used a research network of family
practitioners. Fifty-eight independent offices, urban and
rural, and one primary care outpatient clinic from Wes-
tern Switzerland recruited patients from March to June
2001. Family practitioners consecutively enrolled all
patients over 16 years of age who reported any type of
chest pain during their visits (n = 672). The presence of
chest pain was ascertained according to the usual prac-
tice of each family practitioner. Chest pain due to
obvious causes such as trauma or known body metas-
tases were also included. Patients with anginal equiva-
lents alone, such as jaw pain, dyspnea on exertion, arm
pain, and so on, were therefore excluded. Chest pain
was not necessarily the chief complaint on presentation.
Participating physicians had an average term of experi-
ence in private practice of 12 years (range 1 to 24).
They received detailed information on the study and
were trained to fill in the forms during a special meet-
ing. Each patient gave informed consent to participate
in the study. The study protocol was approved by the
official state local Ethical Committee (Prot. 41/2000).
Data collection
Physicians completed the first part of the Case Report
Form (CRF) during the patient’s index visit. Additional
follow-up information was obtained after three and
twelve months (additional encounters). All completed
forms were sent to the study coordination center. A set
of predefined criteria was used for data entry checks.
The data entry clerk reported inconsistencies to the
principle investigators, who contacted physicians when
needed for case resolution. Missing data were completed
by contacting physicians by telephone and obtaining
answers from the patient’s record. Double data entry
was used to identify transcription errors. Data cleaning
and validation was performed by a group of physicians
experienced in research. When the diagnosis reported
by the family practitioner was not consistent throughout
the year of follow-up, the final diagnosis for chest pain
was discussed and approved by a group of clinicians
who were not aware of the aim of this study.
Predictive factors
We recorded general patients’ information as well as
type, characteristics and location of chest pain. Chest
pain was either already known or a new symptom. An
initial plausible etiology, or early diagnosis, was noted.
The first part of the CRF included 70 questions on his-
tory and clinical signs of chest pain, of which 12 ques-
tions concerned factors that were known to be
associated with CHD [6], and four concerned factors
that were known to be unrelated to CHD (Table 1).
These 16 factors of interest were chosen before any ana-
lysis as potential predictors of CHD. All variables,
except age, were dichotomized, using the usually
described cut-off points [6]. Having a cardiovascular risk
was defined as having at least one known risk factor
(that is, hypertension, hyperlipidemia, diabetes mellitus,
smoking, family history of cardiovascular disease
(CVD)). Our study then focused on either known pain
characteristics related to CHD, or clinical signs exclud-
ing CHD. The studied predictors are given in Table 1.
Outcomes and follow-up
In a primary care setting, it is very difficult to have all
patients’ cardiovascular status assessed using a gold
standard. We therefore opted to use a delayed diagnosis
over one year to detect patients with CHD. During the
initial visit, the suspected diagnosis was noted and then
confirmed or modified during follow-up. Detailed infor-
mation on patients’ history and physical examination,
level of anxiety expressed by patients and physicians,
cardiovascular and thrombo-embolic risk factors, labora-
tory results obtained in emergencies, co-morbidities,
medications, and treatment decisions at the end of the
consultation were also collected. CRFs included infor-
mation on further examinations and laboratory assays,
referrals to specialists, admissions to emergency wards,
hospitalizations, and health events during the follow-up
period. The diagnoses retained after 12 months of fol-
low-up were grouped in six categories: chest wall, CHD,
psychogenic, respiratory, digestive, and miscellaneous.
CHD included angina pectoris, unstable angina, and
myocardial infarction (MI). When the diagnosis of chest
pain was inconsistent or uncertain through the follow-
up, a group of investigators discussed the case. When
the group of investigators was unable to confirm the
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the patient was contacted for further information
through his family practitioner. If the patient could not
be contacted, the diagnosis at three months was
retained. Ten percent of all CRFs were revised by the
group of investigators in evaluating the consistency of
the final diagnosis.
External validity
External validity was done using data from a German
(Marburg) study. Briefly, 1,199 patients aged 35 and over
with chest pain observed in one of 74 family practitioners’
offices in Germany were successively included in this
study. Chest pain was previously unknown and present for
a maximum of one month. Patients were followed-up dur-
ing six months. Cases were defined as patients having
been diagnosed with CHD during the following six
months by experts who were blinded to patients’ clinical
conditions. Variables used from this study were age, sex,
cardiovascular risk, history of CVD, presence of retroster-
nal chest pain, pain triggered by exertion, and pain at pal-
pation. Having a cardiovascular risk was defined as having
at least one of the following characteristics: family history
of CVD, diabetes, hypertension or treated hypertension,
hyperlipidemia or treated hyperlipidemia, smoking or obe-
sity (Body Mass Index ≥30).
Statistical analysis
From previous studies we expected a prevalence of CHD
of 10%. The study was powered to detect factors for
which the risk of CHD was increased by two (20% vs.
10%) with b s e ta t0 . 2a n da at 0.05. The smallest
expected exposure group was the one including patients
with previous history of CVD (20%). This required
Table 1 Distribution of analyzed variables according to diagnostic group and unadjusted Odds Ratio over the
derivation cohort.
Variables Validation
cohort
Derivation
cohort
(n = 774) All (n = 661) CHD group (n = 85) Non-CHD group (n =
576)
OR(unadjusted) (95%
CI)
%% n (%) n (%)
Gender (Male) 42.0% 47.5% 43 (50.6%) 271 (47.0%) 1.2 (0.7 to 1.8)
Age-gender categories
M < 55 yr or F < 65 yr 48.4% 57.8% 6 (7.1%) 376 (65.3%) 1
M 55 to 64 yr or F 65 to 74 yr 26.0% 14.1% 17 (20.0%) 83 (14.4%) 12.8 (4.9 to 33.5)
M ≥ 65 yr or F ≥ 75 yr 25.6% 27.1% 62 (72.9%) 117 (20.3%) 33.2 (14.0 to 78.7)
Known CVR
None 21.2% 34.5% 2 (2.3%) 226 (39.2%) 1
1-2 53.2% 50.5% 46 (54.1%) 288 (50.0%) 18.1 (4.3 to 15.8)
≥3 25.6% 15.0% 37 (43.5%) 62 (10.8%) 67.4 (15.8 to 287.6)
Previous history of CVD 22.0% 18.2% 62 (72.9%) 58 (10.1%) 24.1 (12.5 to 46.4)
Characteristic of the pain
Duration 1 to 60 minutes 42.6% 35.2% 66 (77.6%) 167 (29.0%) 8.5 (4.8 to 15.1)
Increasing on exertion 19.8% 21.3% 37 (43.5%) 104 (18.1%) 3.5 (2.1 to 5.7)
Substernal area pain 57.5% 16.3% 43 (50.6%) 65 (11.3%) 8.0 (4.7 to 13.7)
No tenderness on palpation 57.0% 54.3% 74 (87.1%) 285 (49.5%) 6.9 (3.5 to 13.5)
Sudden excruciating pain n/a 50.1% 34 (40.0%) 297 (51.6%) 0.63 (0.39 to 1.0)
Oppressive pain 43.4% 36.5% 56 (65.9%) 185 (32.1%) 4.1 (2.5 to 6.7)
Irradiation 14.0% 9.1% 8 (9.4%) 52 (9.0%) 1.0 (0.5 to 2.3)
Not position dependant n/a 75.8% 77 (90.6%) 424 (73.6%) 3.5 (1.6 to 7.4)
Not increased with breathing 78.2% 76.5% 80 (94.1%) 426 (74.0%) 5.6 (2.2 to 14.4)
Digestive symptoms 29.0% 24 (28.2%) 168 (29.2%) 0.96 (0.58 to 1.6)
Context
Known patient 91.3% 91.1% 80 (94.1%) 522 (90.6%) 1.7 (0.64 to 4.3)
New complaint n/a 48.8% 19/83 (22.9%) 295/561 (52.6%) 0.27 (0.15 to 0.46)
Emergency n/a 29.1% 19 (22.3%) 173/574 (30.1%) 0.67 (0.39 to 1.1)
Principle complaint 89.3% 52.8% 42/84 (50.0%) 305/573 (53.2%) 0.88 (0.56 to 1.4)
CVR status unknown (no lab) n/a 4.8% 2 (2.3%) 30 (5.2%) 0.44 (0.1 to 1. 9)
CHD = coronary heart disease; CVD = cardiovascular disease; CVR = cardiovascular risk; OR = odds ratio
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without, or a total of 637 patients with chest pain.
Expecting 10% lost to follow-up or missing data, we
rounded this to 700 patients. Bivariate analyses were
performed to identify factors associated with CHD in
patients with chest pain. Fishers’ exact test was used.
Variables associated with CHD (P <0 . 1 )w e r ee l i g i b l e
for inclusion in a multivariable logistic model. A variable
was retained in the model if it significantly contributed
to the model (P < 0.05). Goodness of fit was assessed by
means of the Hosmer and Lemshow test. A score was
then defined on the basis of the coefficients of the logis-
tic regression, and rounded to the nearest unit. Area
under the receiver operating characteristic (ROC) curve
was an indicator of the discriminatory power of the
score. The coefficient of the logistic model with CHD as
the dependent variable and the score as the unique
independent variable was estimated as a second perfor-
mance index [15]. Risk categories were defined on the
basis of two cut off values of the score: percentile 5 of
the CHD group for the low-risk category, and percentile
95 of the non-CHD group for the high-risk category.
Patients with a score between these two cut-off values
were considered at intermediate-risk. The sensitivity and
specificity of the prediction rule for discriminating low-
from intermediate- or high-risk cases indicated the clas-
sification performance of the score. The prevalence of
CHD at given score levels and risk categories was deter-
mined, and the mean of the estimated individual prob-
abilities was given. Sensibility analysis was performed to
assess the effect of not considering patients with
unknown cardiovascular risk status to be at risk. Data
were reanalyzed, considering patients with unknown
cardiovascular risk status as patients having a risk.
Internal validity was assessed by means of bootstrap-
ping techniques [16]. The whole analysis was replicated
on 300 different samples of the same size drawn with
replacement from the original sample. Following the
same algorithm, new scores and new prediction rules
(based on new cut off values) were defined and applied
to the original sample and also to the bootstrapping
sample. The area under the ROC curve was computed,
as well as the calibration index and the sensitivity and
specificity of the rule to classify low risk patients. The
mean and standard deviation (SD) of the areas under
the curves of the 300 scores, applied to the bootstrap
samples and to the original sample, mean and standard
deviation of the calibration index, applied to the boot-
strap sample and to the original sample, and the mean
and SD of the sensibilities and specificities of the 300
rules applied to the original sample were obtained. The
mean number of times that patients, originally classified
as low-risk, were reclassified in the low-risk category,
and then the mean and SD of the predicted values were
computed for each patient. Finally, the mean of the
mean and SD of the predicted values were given for
each score level and risk category.
For external validation, the area under the ROC curve,
sensitivity, specificity, negative likelihood ratio and
occurrence of CHD in each risk group were calculated
f r o mt h ed a t aa v a i l a b l ef r o mt h eM a r b u r gS t u d y[ 1 4 ] .
Only patients with complete data were included in ana-
lysis. All calculations were performed with StataCorp.
2008, Statistical Software: Release 10.0., Stata Corpora-
tion, College Station, Texas, USA.
Results
Altogether, 672 patients were included in the study.
Twenty-seven patients were lost to follow-up at one year.
Their CHD status reported at three months was therefore
carried forward and these patients were included in the
analysis. Excluded patients were those having missing
data on baseline cardiovascular risk status (n = 6) or
were younger than 16 (n = 5). In the remaining group of
661 patients, an average of 11.2 (SD, ±7.6) patients were
recruited in each of the 59 centers. The total practice-
year we followed was of 4.8 years including Thursdays,
Saturdays and Sundays when practices are closed. This
corresponds to an average of 0.7 patients with chest pain
for every GP for every working day. The recruitment per-
iod was nevertheless not the same between physicians.
Eleven physicians stopped recruiting before they were
meant to. If we overview the intervals from which
patients were recruited for each physicians, inclusion was
constant over time. Physicians apparently either stopped
recruiting or continued recruiting per protocol. The
mean age of patients included in analysis was 55.4 years
( S D± 1 9 ) ,a n d3 1 4p a t i e n t s( 4 7 . 5 % )w e r em a l e .M o s t
patients (602, 91.1%) were already known to their family
practitioners, and 314 (47.5%) had never experienced the
same type of pain before. One hundred and twenty
patients (18.2%) had previous evidence of CHD or CVD
(revascularization procedures, heart failure, or peripheral
arterial disease) and 433 patients (65.5%) were known to
have one or more cardiovascular risk factors, 196 were
known to have none. The presence of cardio-vascular
risk was unknown to the physician for 32 of the 661
patients. Eighty-five patients (12.9%) were diagnosed with
CHD, including 75 cases of angina pectoris (11.1%), six
cases of unstable angina (0.9%) and four cases of myocar-
dial infarction (0.6%). None of the 196 patients for which
it was known that they had no risk factor, and two of the
32 patients with unknown laboratory status were diag-
nosed with CHD.
Building the prediction score
Bivariate analyses identified 11 variables associated with
CHD at a significance level of P=0.1 (Table 1). The
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history of CVD, substernal pain location, duration of
pain, pain during exertion, absence of tenderness,
oppressive pain, sudden excruciating pain, pain depen-
dent of the position, pain increased by a deep breath
and previously having felt the same pain. Not knowing
if patients had dyslipidemia or diabetes (n = 32) was not
associated to having CHD (Odds Ratio = 0.44; CI 95%
0.1 to 1. 9).
Age and gender were combined in a single ordinal vari-
able; men <55 and women <65 made the reference
group. Men from 55 years to 64 years and women from
65 years to 74 years were coded 1, and men 65 years or
over and women 75 years or over were coded 2. Pre-
viously having a similar complaint was confounded by
other factors (b = 0.59; P = 0.131). Including all 661
patients in the regression model, the following variables
were not significant at a P = 0.05 level: previously having
a similar complaint (b =0 . 3 5 ;P = 0.509), not position
dependent (b = 0.35; P = 0.509), sudden excruciating
pain (b = -0.49; P = 0.159), oppressive pain (b = 0.65; P =
0.070), and not increased by a deep breath (b =1 . 3 ;P =
0.059). These variables were excluded, and the coefficient
of regression was computed for the seven remaining pre-
dictors (Table 2). Goodness-of-fit test of the model
showed a good fit between expected and observed fre-
quencies of covariate patterns (P = 0.250). The absence
of any clustering effect for physicians was confirmed
using random-effects logistic regression (r = 0.0112; P =
0.336). Adjusting for clustering had no effect on CHD
score values. Only two cases were not identified at three
months and were reported as such during the follow-up
period. Results of the logistic regression excluding these
two cases remain the same.
The regression coefficients, OR (adjusted and unad-
justed) are given in Table 2, as well as the contribution
of each factor to the CHD score. The score ranged from
0 to 11. The model allowed two points each for the fol-
lowing determinates: having a known cardiovascular
risk, men over 55 years or women over 65 years, perso-
nal history of CVD, and substernal pain. The other
determinants, duration, exertion with effort, and tender-
ness, each received one point.
The area under the curve (AUC) of the receiver oper-
ating characteristics (ROC) (Figure 1) was 0.946 (95%
CI, 0.924 to 0.968). The model showed a good overall
performance (R
2 = 0.538). The cut-off point for low-risk
(defined as the fifth percentile of the CHD patients) was
5. Thus, the 413 (62.5%) patients with scores <5 were
defined as low-risk. In the low-risk group, one patient
was diagnosed with stable angina and another with
myocardial infarction during the following 12 months.
The sensitivity of this rule is 97.6% (83/85), the specifi-
city 71.3% (411/576), the negative likelihood ratio of
0.033, and the negative predictive value of 99.5% (411/
413).
The cut off point for high-risk (defined as the 95
th
percentile of the non-CHD group) was 7. According to
this rule, 87 patients (13.2%) with scores >7 were
defined as being at high-risk. Finally, 161 patients
(24.4%) were classified as intermediate-risk. The preva-
lence of CHD in the low-risk category was 0.5% (2/413),
12.4% (20/161) in the moderate category and 72.4% (63/
87) in the high-risk category (Table 3).
Table 2 Regression coefficients, contributions to the CHD-score, ORs (adjusted) for the subpopulation with
cardiovascular risks (n = 435).
Variables Regression Coefficient Score ORadjusted *
ORadj (95% CI)
Age-sex categories
M < 55 yr or F < 65 yr 0 0 1 (reference)
M 55-64 yr or F 65 to 74 yr 1.99 2 7.3 (2.4 to 22.5)
M ≥ 65 yr or F ≥ 75 yr 2.44 2 11.5 (4.2 to 31.5)
Known cardiovascular risk
None 0 0 1 (reference)
1 to 2 1.76 2 5.8 (1.2 to 29.0)
≥3 1.91 2 6.7 (1.3 to 35.2)
Known previous history of CVD 1.89 2 6.7 (3.2 to 13.8)
Duration of chest pain 1 to 60 minutes 1.09 1 3.0 (1.4 to 6.2)
Area of pain described as substernal 1.65 2 5.2 (2.5 to 10.9)
Precipitating with exertion 0.75 1 2.1 (1.0 to 4.3)
Absence of tenderness 1.22 1 3.4 (1.5 to 8.0)
* Adjusted for variables shown in this table.
CHD = coronary heart disease; CVD = cardio-vascular disease; OR = odds ratio;
ORadj = adjusted odds ratio
Gencer et al. BMC Medicine 2010, 8:9
http://www.biomedcentral.com/1741-7015/8/9
Page 5 of 10Classification of major events and electrocardiograms
(ECG)
Table 3 shows the prevalence of major events for each
risk class. We observed one patient with acute myocar-
dial infarction classified as low-risk. This patient’s cardi-
ovascular risk status was unknown. During the year of
follow-up, 24 patients died. Four of them belonged to
the low-risk group. None of these patients were diag-
nosed with a CHD. It is worth mentioning that 72
ECGs were taken of low-risk patients, representing
50.3% of all the ECGs done on patients with chest pain.
For high-risk patients, less than one third were investi-
gated by ECG.
Internal validity
The results of the 300 iterations of score development
(bootstrapping) gave consistent results with the initial
analysis, except for 40 samples. The mean area under
the curve for the 300 different prediction rules applied
to the original sample was 0.942 (SD 0.004), and the
mean calibration index was 0.87 (SD 0.13). When the
predictive rules where applied to the bootstrap samples,
we had a mean area under the curve of 0.950 (SD
0.011), and a mean calibration index of 0.97 (SD 0.07).
The difference between both calibration indexes
revealed the over-optimism of the model. The dispersion
of the calibration index revealed some kind of instability
of the model (due to the very small number of CHD in
the group without known risk factor). Mean sensitivity
and specificity for the rule-out threshold values were
0.956 (SD 0.027) and 0.710 (SD 0.077), respectively.
Nevertheless, the classification appears to be relatively
stable because the 392 patients in the low-risk category
were classified on average 283.35 times (range 149 to
300) in the low-risk category by the bootstrap rules. The
mean prevalence of CHD in the low-risk category was
0.005 (SD 0.005). The distribution of the prevalence of
CHD by risk category is given in Table 3 where the
score distribution is compared with the actual preva-
lence. The mean predicted values and mean deviation
from original predicted values are given by risk category.
External validity
D a t af r o mt h eM a r b u r gs t u d yw e r em a d ea v a i l a b l ef o r
validation [14]. From the data collected from 1,199 suc-
cessive patients with chest pain attending 74 general
practitioners full data were available for 774 patients
that were included in the analysis. Prevalence of CHD
0
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Figure 1 Receiver operating characteristics curve for the Ambulatory CHD score in both derivation and validation cohorts.
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analysis (14.7%) and those who were excluded for miss-
ing data (12.3%). The area under the curve was of 0.752
(95% CI 0.716; 0.809). Prevalence of CHD in the low
risk category (score <5) was of 5.2% (Table 3). The rul-
ing out of CHD using the CHD-Score has a sensitivity
of 85.6% and a specificity of 47.2%. Negative likelihood
ratio was of 0.305 and negative predictive value of
94.8%. The prevalence of CHD for each score value is
given in Figure 2. Among the 15 patients with CHD in
the low risk group, one had acute myocardial infarction
and one had unstable angina.
Discussion
We developed a clinical prediction score for ruling out
CHD in primary care patients with chest pain. Our
CHD score includes eight predictors (age, gender, hav-
ing at least one CVD risk factor, history of CVD, dura-
tion of pain, substernal location of pain, increased pain
with exertion, absence of tenderness at palpation),
which are all known to be associated with CHD [6], and
easily identifiable from history and physical examination.
Our score can classify patients in three groups with an
increasing prevalence of CHD. Bootstrapping, the
recommended tool for this kind of modeling [15], was
used to test internal validity. Our ambulatory CHD
score is consistent throughout our data, and the predic-
tive power of the model is acceptable. Our ruling-out
score classified two thirds of the studied population in
the low-risk category with a strong negative predictive
value (99.8%). Negative predictive value remained high
in the validation cohort (94.8%) with a negative likeli-
hood ratio of 0.31. Our ambulatory CHD score seems
adapted for the management of CHDs in primary care.
However, this score does not entirely rule out CHD as
5.2% of patients in the low risk group from the valida-
tion cohort ended up having CHD within the next six
months.
Our data show both similarities and differences from
the published determinants used to rule out CHD. The
American College of Physicians [4] developed guidelines
to manage patients in primary care for whom chronic
stable angina was suspected. Our scores are in agree-
ment with their recommendations of using age, gender,
cardiovascular risk factors, and pain characteristics to
estimate the probability of CHD. Like the Framingham
risk score [5], our ambulatory CHD score also includes
age, gender, and cardiovascular risks as indicators of
CHD events. The Framingham risk score does not
include a personal history of CVD or characteristics of
pain, which are essential to detecting patients with
CHD. These characteristics have been included in scores
developed in emergency departments [7,8,17-25]. How-
ever, the prevalence and etiology of CHD differ consid-
erably between these two settings. CHD is about four
times less frequent in patients with chest pain in pri-
mary care [1] than in those admitted in emergency
departments [26]. Furthermore, the severity of CHD dif-
fers between these settings. Over 10% of patients hospi-
talized with chest pain [26,27] have a myocardial
infarction, whereas we observed a prevalence of only
0.6% in primary care [3]. Factors that may appear to be
important or unimportant in samples with relatively few
outcome events may be substantially misleading. For
example, pain lasting for more than 60 minutes is very
atypical for angina but not so unusual for an acute
Table 3 Prevalence of events for each level of risk.
Events Low-risk CHD
Score = 0-4
n = 413
Intermediate-risk
CHD Score = 5-7
n = 161
High-risk
CHD Score = 8-11
n =8 7
n % (CI 95%) n % (CI 95%) n % (CI 95%)
Coronary Heart Disease
Observed 2 0.5% (0.0 to 1.7) 20 12.4% (7.8 to 18.5) 63 72.4% (61.8 to 81.5)
Prevalence from bootstrapping* 0.7 (0.6) 14.6 (10) 69.4 (16)
Validation cohort (N = 774) † 15/289 5.2% (3.0 to 8.4) 40/327 12.2% (8.9 to 16.3) 59/158 37.3% (29.8 to 45.4)
Acute myocardial infarction 1 0.2% (0 to1.3) 1 0.6% (0 to 3.4) 2 2.3% (0.3 to 8.1)
Unstable angina 0 0% (0 to 0.9) 2 1.2% (0.2 to 4.4) 4 4.6% (1.3 to 11.4)
Deaths
Overall 4 1.0% (0.3 to 2.5) 11 6.8% (3.5 to 11.9) 9 10.3% (4.8 to 18.7)
CVD 0 0% (0 to 0.9) 2 1.2% (0.2 to 4.4) 9 10.3% (4.8 to 8.7)
CHD 0 0% (0 to 0.9) 2 1.2% (0.2 to 4.4) 7 8.0% (3.3 to 15.9)
Mean and SD of predicted values according to the risk category (bootstrapping).
* Mean prevalence in each risk category (with SD) given by the 300 bootstrap rules (%)
† Data drawn from the German cohort (Marburg study)
CHD = coronary heart disease; CVD = cardio-vascular disease
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Page 7 of 10myocardial infarction. Given the very low prevalence of
myocardial infarction in this manuscript, factors that
may be very important for diagnosing acute myocardial
infarction may be substantially undervalued. This could
explain why the area under the curve for predicting
CHD seems better in our score than for either the
TIMI, the PURSUIT or the GRACE scores [28]. This
difference illustrates the importance of developing
guidelines and scores specifically for the primary care
setting instead of a mere use of scores developed for
emergency department patients.
The major strength of our study is the development of
ac l i n i c a lt o o lf o rf a m i l yp r a c titioners, using data col-
lected by a research network in primary care [29]. The
use of the ambulatory CHD score, based only on the
patient’s history and physical examination, allows family
practitioners to estimate risks of discharging a patient
without further examinations.
Our study has some limitations. We would first like to
remind physicians that scores derived from logistic
regression cannot identify unusual presentations. Con-
sider the example of a young patient who abuses
cocaine, and presenting an acute myocardial infarction.
This patient would be classified in the low-risk group
[30]. Clinical knowledge and experience therefore still
remain essential in ruling out CHD in patients with
chest pain [31,32]. Secondly, we used delayed diagnosis
instead of referring all patients to a specialist. Logistical
resources and patients’ unavailability make it very
difficult to assure objective confirmation in primary care
research. Furthermore, in the derivation cohort, asses-
sors were not blinded to the initial state of exposure
when defining cases. However, 28% of the patients have
been referred to specialists or to hospitals, and the one-
year follow up allows us to reasonably confirm the
absence of missed CHD. Furthermore, in cases of doubt,
the family practitioner was questioned for further infor-
mation. In the 10% of records reviewed by experts, only
one controversial case was detected and resolved after
discussion with the family practitioner. We therefore
believe that misclassification is negligible. It should be
noted that most patients were known to their primary
care physicians, a factor that could have facilitated the
diagnostic process. Physicians were therefore not
blinded to their patient’s condition and could have been
more likely to report some signs knowing their patient
had cardiac chest pain. Furthermore, we cannot exclude
that patients with MI or unstable angina which rapidly
became entirely asymptomatic remained undetected.
The study is also underpowered to detect any difference
in myocardial infarction or unstable angina between the
risk groups. Finally, external validation showed the score
to be much less sensitive than it was meant to be. Both
studies however included different patients. In the Mar-
burg study, young patients were not included (≥35 years
vs. ≥16 years), nor were those with posterior chest pain
or pain lasting more than one month. The Marburg
study therefore excluded patients who were more likely
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Page 8 of 10to be at low risk compared to those included in the Lau-
sanne cohort. This method nevertheless shows a better
diagnosis ability than recognized laboratory markers
such as BNP and NT-proBNP [33] in possible heart fail-
ure patients.
Conclusions
In summary, we developed a clinical prediction score to
rule out CHD in primary care patients with chest pain.
This clinical tool may limit clinical investigation in
patients with chest pain in primary care where the pre-
sentation and the management are completely different
from the emergency departments. However, further ana-
lyses of the proposed score should be conducted in var-
ious primary care contexts to evaluate its true benefit
better and evaluate its implementation.
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